What Is the Tuberculosis Reservoir and How Does TB Spread?

The primary tuberculosis reservoir is the human population itself, specifically the estimated 1.7 billion people worldwide who carry a latent infection with Mycobacterium tuberculosis in their bodies without showing symptoms. TB spreads mainly through the air when someone with active lung disease exhales tiny particles containing the bacterium, though the details of how those particles are generated, who produces them, and where transmission actually happens are more complex than the textbook version suggests.

The Human Reservoir Is Enormous

When epidemiologists talk about a disease reservoir, they mean the population or environment where the pathogen persists between outbreaks. For TB, that reservoir is overwhelmingly human. A mathematical modeling study estimated that about 23% of the world’s population, roughly 1.7 billion people, were latently infected with M. tuberculosis as of 2014.¹ A later systematic review using data from both blood-based and skin-test surveys arrived at a similar figure, finding that roughly one quarter of the global population carries the infection.² The vast majority of these people will never develop active disease. Their immune systems keep the bacterium walled off in tiny granulomas in the lungs or elsewhere. But the sheer size of this pool means that even a small percentage progressing to active TB each year generates millions of new cases.

About 56 million of those latently infected individuals had picked up their infection within the prior two years, placing them at the highest risk of progression to active disease.¹ Recent infection carries the steepest risk: most people who do develop active TB do so within the first year or two after being exposed. After that window, the risk drops substantially but never reaches zero. This two-tier dynamic, a massive background pool with a smaller high-risk recent layer on top, is what makes TB so difficult to eliminate. You cannot treat your way out of it by focusing only on active cases; the reservoir keeps refilling.

How TB Moves Through the Air

TB is fundamentally an airborne disease. When a person with active pulmonary TB breathes, talks, coughs, or sings, they release aerosol particles small enough to stay suspended in the air for hours. These droplet nuclei, typically under five micrometers in diameter, can be inhaled deep into the lungs of anyone sharing the same airspace. That is the core transmission route, and it distinguishes TB from infections that spread mainly by larger respiratory droplets or by touching contaminated surfaces.

A widespread assumption is that coughing is required for someone to be infectious. Research has challenged this directly. A review of the evidence concluded that coughing is not a necessary prerequisite for TB transmission, because all breathing activities can release aerosol from the lung periphery, where TB disease typically sits, via a mechanism involving the bursting of thin fluid films in the small airways.³ Cough frequency correlates with infectivity, but that does not mean coughing causes the transmission; rather, more severe lung disease produces both more coughing and more bacterial aerosol independently.

A study that directly sampled the air around TB patients during quiet, relaxed breathing found viable M. tuberculosis in over 90% of patients even without any coughing during the sampling period. When they compared five minutes of coughing to five minutes of a specific breathing maneuver designed to rupture those airway fluid films, both produced essentially the same median number of bacteria.⁴ The practical implication is sobering: a person with active TB does not need to be visibly coughing to be putting the bacterium into the air around them. The absence of cough should not be taken as reassurance that someone is not infectious.

Subclinical TB and the Transmission Gap

This matters even more when you consider that a large share of people with bacteriologically confirmed TB report no classic symptoms at all. Subclinical TB refers to people who have detectable bacteria in their sputum but who do not report the hallmark complaints of cough, fever, night sweats, or weight loss. These individuals are typically found through community screening rather than by seeking care.

The question of how infectious they are has only recently been studied closely. A household contact study found that children living with subclinical, smear-positive TB patients had a similarly elevated risk of becoming infected compared to children living with patients who had full-blown clinical symptoms.⁵ An individual patient data analysis spanning 14 countries estimated that subclinical TB may account for roughly two-thirds of all TB transmission globally, largely because these cases go undiagnosed and untreated for longer periods.⁶ That estimate carries wide uncertainty, but the direction of the finding is striking: the people nobody knows are sick may be driving more transmission than the ones in clinics getting treated.

Not All Patients Are Equally Infectious

Even among people with active pulmonary TB, the amount of bacteria they put into the air varies wildly. Some patients generate large numbers of viable bacteria in their cough aerosols; others produce almost none. Research on what makes someone a high-output aerosol producer has pointed to a few host and disease characteristics. Patients who are cough-aerosol culture positive, meaning live TB bacteria can be grown from what they exhale, tend to have cavities in their lungs and more extensive disease visible on chest X-ray.⁷ Cavities are open spaces in the lung tissue packed with bacteria, and they connect directly to the airways, providing a direct route for bacilli to reach exhaled air.

But bacterial load alone does not fully explain who transmits. The correlation between the amount of bacteria in sputum and whether the patient’s cough aerosol grows in culture is only moderate, meaning other factors like lung anatomy, breathing patterns, and possibly the bacterium’s own biology play a role. This heterogeneity has implications for control: a small number of highly infectious individuals may drive a disproportionate share of transmission in any community, a pattern sometimes called superspreading.

Where Transmission Happens

Because TB is airborne and the particles stay suspended for hours, transmission depends heavily on shared indoor airspace. Any enclosed, poorly ventilated environment where people spend prolonged time together creates risk. Households are the most obvious setting, and genomic studies confirm their importance. A prospective cohort study in Lima, Peru, that used whole-genome sequencing to distinguish true household transmission from coincidental community exposure found that among pairs where one person developed TB after the index case, about two-thirds were genetically linked, meaning the bacterium was genuinely passed within the home.⁸ That still leaves a substantial minority of cases that were acquired outside the home, underlining that community transmission also matters.

Prisons represent one of the most concentrated transmission environments globally. TB incidence among inmates is estimated at roughly ten times higher than in the general population, driven by overcrowding, poor ventilation, malnutrition, high rates of HIV co-infection, and delayed diagnosis.⁹ Prisons are not sealed systems; inmates cycle in and out, carrying infections into surrounding communities. In high-burden countries, prison-linked transmission chains seed cases well beyond the facility walls.

Healthcare facilities pose their own risks. Nurses and other workers who spend prolonged time on wards with undiagnosed TB patients face occupational exposure, particularly where infection prevention measures are inconsistent.¹⁰ The basic problem is the same in all these settings: an infectious person exhaling bacteria into a shared, poorly ventilated space over hours or days.

Ventilation and Ultraviolet Light as Barriers

Because TB particles float, the most effective engineering interventions target the air itself. Adequate ventilation, whether natural or mechanical, dilutes the concentration of infectious particles and is considered the highest priority among environmental controls.¹¹ In clinical settings where adequate ventilation is hard to achieve, supplemental technologies like HEPA filtration and upper-room ultraviolet germicidal irradiation (UVGI) can fill the gap.

Upper-room UVGI works by directing ultraviolet light across the upper portion of a room, above people’s heads, to kill bacteria in the air as it circulates upward. A controlled trial using guinea pigs exposed to air from a TB ward found that upper-room UV reduced TB transmission by about 80%.¹² Modeling of a hospital ward setting estimated inactivation rates for M. tuberculosis in the range of 68 to 90% in a neighboring patient’s breathing zone, depending on the position of the UV unit and the airflow pattern.¹³ These technologies are not theoretical curiosities; they are practical tools already deployed in hospitals and congregate settings, though far less widely than the evidence warrants.

Animal Reservoirs and Zoonotic Transmission

While humans dominate the TB reservoir, they are not the only one. Mycobacterium bovis, a close relative of M. tuberculosis within the same bacterial complex, naturally infects cattle and can spread to humans. The classic route is consumption of unpasteurized milk or dairy products from infected cows.¹⁴ In countries with strong pasteurization programs and cattle testing, this route has been largely eliminated. In parts of Africa and South Asia where raw milk consumption is common and cattle screening is limited, M. bovis still contributes to human TB. A study in central Ethiopia, for example, found M. bovis among human TB isolates, though M. tuberculosis remained far more common.¹⁵

Wildlife reservoirs complicate cattle-to-human control efforts by reinfecting herds even after they have been cleared. European badgers in the UK, brushtail possums in New Zealand, white-tailed deer in North America, feral pigs in parts of Europe, and African buffalo in South Africa all harbor M. bovis and transmit it back to domestic cattle.¹⁶ In Minnesota, an outbreak investigation found the same strain of M. bovis in both free-ranging white-tailed deer and nearby cattle operations, all concentrated within a small geographic area.¹⁷ In the UK, badger social organization and land-use patterns bring them into close contact with grazing cattle, making the epidemiology particularly difficult to untangle.¹⁸

The traffic is not one-way. In high-burden countries, human M. tuberculosis can jump to animals, a process called reverse zoonosis. This is concerning because it could establish drug-resistant strains in animal populations, creating new reservoirs that are even harder to control.¹⁹

Can TB Survive in the Environment?

TB is often described as a disease that spreads person to person, full stop. The environmental angle tends to be downplayed. But M. tuberculosis is a remarkably tough organism. A review of experimental and epidemiological evidence found that the bacterium can remain viable in soil, dust, and water for months to years after being deposited by a human source.²⁰ A study in a metropolitan city found that bacilli in contaminated soil remained culturable in some samples for up to nine months.²¹

Wastewater is another detection site. TB bacteria have been found in both treated and untreated wastewater, raising questions about potential exposure for sanitation workers and communities living near treatment plants.²² The practical significance of environmental TB exposure is still debated. Airborne person-to-person transmission accounts for the overwhelming majority of cases. But environmental persistence may matter in specific scenarios, like heavily contaminated shelters or institutions, and it is one reason infection control in high-burden settings needs to consider more than just current occupants of a room.

The Evolutionary Story Behind the Reservoir

For a long time, scientists assumed that human TB originated in cattle and jumped to people after domestication. Genomic evidence has flipped that narrative. The M. tuberculosis complex appears to have emerged as a human pathogen in Africa and spread with humans during the Out-of-Africa migrations tens of thousands of years ago.²³ Cattle-adapted lineages like M. bovis likely diverged later, meaning the flow was from humans to animals rather than the reverse. More recently, “modern” lineages of M. tuberculosis expanded alongside global population growth and then traveled the world along routes of trade, colonization, and migration.²⁴

This long coevolutionary history helps explain why TB is so well adapted to humans. The bacterium has evolved alongside our immune system for millennia, learning to survive inside the very immune cells meant to kill it. It also explains the geographic patterning of TB lineages. Mycobacterium africanum, which causes a significant fraction of TB cases in West Africa, belongs to two older lineages (lineage 5 and lineage 6) that are largely restricted to that region.²⁵ Cases of M. africanum outside West Africa are almost always found in people of West African descent.²⁶ Norway, for instance, has documented imported cases and even limited transmission of M. africanum among immigrant communities.²⁷

What Tips the Balance From Latent to Active

Because the reservoir is so large and the bacterium can persist for a lifetime, the factors that trigger reactivation matter enormously. HIV is the most powerful driver: the virus depletes the immune cells that keep TB in check, and co-infected individuals have a dramatically higher annual risk of developing active disease. Diabetes is another recognized risk factor. Animal research has shown that sustained high blood sugar can promote the expression of bacterial genes involved in waking dormant TB bacilli, essentially nudging them from a sleeping state toward active growth.²⁸

Interestingly, having diabetes as a TB patient does not appear to make you more likely to transmit the disease to others. A large household contact study found that the diabetes status of an index TB patient was not associated with higher rates of TB infection or disease in their household contacts. In fact, household contacts of TB patients with diabetes had a lower incidence of developing TB disease during follow-up.²⁹ The reasons for this are not entirely clear, but it may relate to differences in the type or location of lung disease that diabetes-associated TB produces.

Other conditions and situations that increase the risk of progression from latent to active TB include organ transplant (due to immunosuppressive medications), silicosis, malnutrition, heavy alcohol use, and treatment with certain biologic drugs used for autoimmune diseases. Aging itself is a risk factor, as the immune system gradually weakens. Each of these conditions chips away at the immune containment that keeps latent TB dormant, converting a silent carrier into an active, potentially infectious case.

Detecting TB in the Air

Traditional TB diagnosis relies on collecting sputum, the phlegm a patient coughs up from their lungs. But given what we now know about aerosol transmission and the role of subclinical cases, researchers have been exploring whether you can detect TB directly from what a person breathes out. One approach uses modified face masks containing filters. A proof-of-concept study had patients wear masks fitted with gelatin filters for one hour, then tested the filter using rapid molecular diagnostics.³⁰ More recent work has refined this approach and explored its potential in children, who are notoriously difficult to diagnose because they rarely produce sputum.³¹

These technologies are still largely experimental, but they point toward a future where TB diagnosis could shift from waiting for a symptomatic patient to produce a sputum sample to actively sampling the air around them or simply having them breathe into a collection device. Given the growing evidence that subclinical and minimally symptomatic patients contribute heavily to transmission, any diagnostic approach that does not require a cough to work has obvious appeal.

Breaking Transmission Chains Around Children

Children under five are especially vulnerable to TB because their immune systems are still developing, and they tend to progress to severe forms of the disease more quickly. When a household member is diagnosed with active TB, contact investigation of the children in that home is a key public health response. The process involves screening child contacts for infection or early disease, then providing preventive therapy to those who are infected but not yet sick.³² Preventive therapy, typically a course of isoniazid or a shorter rifamycin-based regimen, is aimed at killing latent bacteria before they can cause active disease.

Around 11% of recent infections globally involve isoniazid-resistant strains, meaning that the standard preventive regimen would be ineffective for those individuals.¹ This resistance dimension adds a layer of complexity to the effort of shrinking the human reservoir. Preventive therapy works best when the strain is susceptible, and knowing the drug-resistance profile of the source case becomes critical for choosing the right regimen for contacts.